Join to View Full Profile
10506A Montgomery RdMontgomery, OH 45242
Phone+1 513-853-1300
Fax+1 513-451-4118
Dr. Girnius is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston University Medical CenterResidency, Internal Medicine, 2006 - 2009
University of Cincinnati College of MedicineClass of 2006
Certifications & Licensure
OH State Medical License 2013 - 2027
MA State Medical License 2008 - 2013
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM) Start of enrollment: 2021 Apr 20
Roles: Principal Investigator
Publications & Presentations
PubMed
- 1 citations-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma.Robert M Rifkin, Caitlin L Costello, Ruemu E Birhiray, Suman Kambhampati, Joshua Richter
Future Oncology. 2024-01-01 - 2 citationsIn-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management.Robert M Rifkin, Saulius K Girnius, Stephen J Noga, Ruemu E Birhiray, Suman Kambhampati
Blood Cancer Journal. 2023-09-19 - 11 citationsBleeding and thrombotic risk in pregnant women with Fontan physiologyAndrea Girnius, Dominica Zentner, Anne Marie Valente, Petronella G. Pieper, Katherine E. Economy
Heart. 2021-09-01
Abstracts/Posters
- Long-Term Proteasome Inhibitor (PI) Therapy in Community Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Transitioning from Bortezomib (Btz)-Based to Ixazo...Saulius K. Girnius, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Genomic Landscape of Sex Disparities in Multiple MyelomaSaulius K. Girnius, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell TransplantationSaulius K. Girnius, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
